Table 7.

Recommended Surveillance for Individuals with Hereditary Hemorrhagic Telangiectasia

System/ConcernEvaluationFrequency
General Eval by health care provider familiar w/HHT, incl interval history for epistaxis, other bleeding, shortness of breath, ↓ exercise tolerance, headache, & other neurologic symptoms

Annually

Anemia
  • Hematocrit/hemoglobin
  • Ferritin
Pulmonary AVM
  • In adults: TCE w/agitated saline contrast if previous TCE did not reveal evidence of a significant right-to-left shunt
  • In children: TCE w/agitated saline contrast OR chest radiograph w/pulse oximetry
  • In those w/o previous pulmonary AVM: every 5 yrs
  • In those w/pulmonary AVM: frequency per vascular specialist
Cerebral AVM Brain MRI (w/& w/o contrast using sequences that detect blood products)Rpt after puberty if initial brain MRI was done in childhood, as development or evolution of cerebral AVMs in 1st 2 decades of life has been reported [Hetts et al 2014].
SMAD4-HHT See Juvenile Polyposis Syndrome, Surveillance for additional recommendations.Colonoscopy at age 15 yrs; rpt every 3 yrs if no polyps found or annually w/EGD if colonic polyps are identified [Faughnan et al 2020].

AVM = arteriovenous malformation; EGD = esophagogastroduodenoscopy; HHT = hereditary hemorrhagic telangiectasia; TCE = transthoracic contrast echocardiography

From: Hereditary Hemorrhagic Telangiectasia

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.